Jihong Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jihong Zhang has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
- Wei Chen
Medical School, Kunming University of Science and Technology, Kunming 650500, China
5 shared publications - Fan Yang
Medical School, Kunming University of Science and Technology, Kunming 650500, China
4 shared publications Jiajian Wang
Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming 650500, PR China; Laboratory of Molecular Pharmacology, Medical School, Kunming University of Science and Technology, Kunming 650500, PR China
4 shared publicationsFan Yang
Medical School, Kunming University of Science and Technology, Kunming, PR China
3 shared publicationsFei Yu
Laboratory of Molecular Pharmacology, Medical School, Kunming University of Science and Technology, Kunming 650500, PR China
3 shared publicationsLanqing Zhang
Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming 650500, PR China; Laboratory of Molecular Pharmacology, Medical School, Kunming University of Science and Technology, Kunming 650500, PR China
3 shared publications
Latest Publications
- Open Access
Positive-Sense RNA Viruses Reprogramming Membrane Contact Sites to Remodel Organelles and Control Cell Fate
Eukaryotic cells rely on a highly coordinated organelle network to maintain metabolism, signaling, stress adaptation and cell survival. Membrane contact sites (MCSs) provide essential platforms for inter-organelle communication. As obligate intracellular parasites, less attention has been given to how viral perturbation of MCSs may reshape the broader organelle communication network. In this review, we focus on positive-sense RNA viruses and virus-induced membrane contact sites (vMCSs), focusing on ER-associated tethering factors, lipid transfer pathways, calcium signaling modules, and replication organelle–host organelle interfaces. Also we discuss how viruses hijack conserved host tethering systems to connect viral replication compartments with lipid transfer machinery. Further, we explore how viruses establish vMCSs that couple replication compartments to host organelles, thereby coordinating cellular homeostasis. Together, these findings suggest that viral remodeling of MCSs should be understood not only as local manipulation of individual organelles but also as a network-level reorganization of cellular homeostasis.
Open AccessPositive-Sense RNA Viruses Reprogramming Membrane Contact Sites to Remodel Organelles and Control Cell Fate
Eukaryotic cells rely on a highly coordinated organelle network to maintain metabolism, signaling, stress adaptation and cell survival. Membrane contact sites (MCSs) provide essential platforms for inter-organelle communication. As obligate intracellular parasites, less attention has been given to how viral perturbation of MCSs may reshape the broader organelle communication network. In this review, we focus on positive-sense RNA viruses and virus-induced membrane contact sites (vMCSs), focusing on ER-associated tethering factors, lipid transfer pathways, calcium signaling modules, and replication organelle–host organelle interfaces. Also we discuss how viruses hijack conserved host tethering systems to connect viral replication compartments with lipid transfer machinery. Further, we explore how viruses establish vMCSs that couple replication compartments to host organelles, thereby coordinating cellular homeostasis. Together, these findings suggest that viral remodeling of MCSs should be understood not only as local manipulation of individual organelles but also as a network-level reorganization of cellular homeostasis.
- Open Access
- 15 July 2026
- Published by Springer Nature in Cell Death & Differentiation
Targeting POLRMT-driven epigenetic remodeling of Wnt/β-catenin to eradicate colorectal cancer stem cell proliferation
Colorectal cancer stem cells (CSCs) drive tumor progression through poorly understood metabolic-epigenetic crosstalk. Here, we identify mitochondrial RNA polymerase POLRMT as a key link connecting mitochondrial transcription to CSC maintenance. Clinically, POLRMT is overexpressed in colorectal cancer (CRC) tissues and correlates with poor prognosis. Genetic ablation or pharmacological inhibition of POLRMT suppresses CSC self-renewal and tumorigenicity across cell line-derived CSCs, CRC organoids, and xenograft models. Mechanistically, POLRMT deficiency triggers mitochondrial dysfunction, which unexpectedly elevates the demethylase KDM6B expression, α-ketoglutarate (α-KG) levels, and Dickkopf-1 (DKK1) expression, thereby transcriptionally silencing Wnt/β-catenin signaling and collapsing the CSC niche. Restoration of β-catenin rescues tumorigenicity in POLRMT-knockout (KO) cells, confirming the hierarchy of this signaling cascade. Crucially, POLRMT catalytic activity and mitochondrial localization are indispensable for sustaining this axis. Our work unveils POLRMT as a metabolic gatekeeper that licenses CSC plasticity through KDM6B–α-KG/H3K27me3-mediated chromatin remodeling, proposing the mitochondrial transcription machinery as a therapeutic target for dismantling the CSC hierarchy in CRC.
- 15 July 2026
- Published by Springer Nature in Cell Death & Differentiation
Open AccessTargeting POLRMT-driven epigenetic remodeling of Wnt/β-catenin to eradicate colorectal cancer stem cell proliferation
Colorectal cancer stem cells (CSCs) drive tumor progression through poorly understood metabolic-epigenetic crosstalk. Here, we identify mitochondrial RNA polymerase POLRMT as a key link connecting mitochondrial transcription to CSC maintenance. Clinically, POLRMT is overexpressed in colorectal cancer (CRC) tissues and correlates with poor prognosis. Genetic ablation or pharmacological inhibition of POLRMT suppresses CSC self-renewal and tumorigenicity across cell line-derived CSCs, CRC organoids, and xenograft models. Mechanistically, POLRMT deficiency triggers mitochondrial dysfunction, which unexpectedly elevates the demethylase KDM6B expression, α-ketoglutarate (α-KG) levels, and Dickkopf-1 (DKK1) expression, thereby transcriptionally silencing Wnt/β-catenin signaling and collapsing the CSC niche. Restoration of β-catenin rescues tumorigenicity in POLRMT-knockout (KO) cells, confirming the hierarchy of this signaling cascade. Crucially, POLRMT catalytic activity and mitochondrial localization are indispensable for sustaining this axis. Our work unveils POLRMT as a metabolic gatekeeper that licenses CSC plasticity through KDM6B–α-KG/H3K27me3-mediated chromatin remodeling, proposing the mitochondrial transcription machinery as a therapeutic target for dismantling the CSC hierarchy in CRC.
- 17 May 2026
- Published by Elsevier in Phytomedicine
- Vol. 157, 158314
Buxus alkaloid KBA01 targets Valosin-containing protein to inhibit colorectal cancer progression via the p53-Wnt/β-catenin axis
- 17 May 2026
- Published by Elsevier in Phytomedicine
- Vol. 157, 158314
Buxus alkaloid KBA01 targets Valosin-containing protein to inhibit colorectal cancer progression via the p53-Wnt/β-catenin axis
- Open Access
- 20 November 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (48) , 59608-59614
Dual-Site Chemically Engineered MNAzymes for One-Pot Isothermal Detection of MicroRNAs
Sensitive detection of microRNAs (miRNAs) remains challenging due to their low abundance and sequence similarity. Conventional DNAzyme- and multicomponent nucleic acid enzyme (MNAzyme)-based assays are enzyme-free but often limited by poor catalytic turnover. Here, we present a dual-site chemically engineered MNAzyme platform that integrates xeno-nucleic acid modification within the catalytic core and locked nucleic acid substitution within the target-binding arms to synergistically enhance catalytic and recognition efficiency. The resulting hybrid, termed LXMz, exhibits an ∼760-fold improvement in catalytic rate and an ∼450-fold increase in sensitivity relative to the unmodified MNAzyme. Under isothermal, one-pot conditions, LXMz achieves the quantitative detection of miR-92a with a limit of detection of 2 pM while maintaining single-base specificity. By combining catalytic enhancement and hybridization stabilization within a unified molecular design, this study establishes a new chemical engineering principle for constructing robust, enzyme-free biosensors. The LXMz framework provides a versatile and sensitive platform for miRNA analysis and holds promise for liquid biopsy and point-of-care diagnostics.
- 20 November 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (48) , 59608-59614
Open AccessDual-Site Chemically Engineered MNAzymes for One-Pot Isothermal Detection of MicroRNAs
Sensitive detection of microRNAs (miRNAs) remains challenging due to their low abundance and sequence similarity. Conventional DNAzyme- and multicomponent nucleic acid enzyme (MNAzyme)-based assays are enzyme-free but often limited by poor catalytic turnover. Here, we present a dual-site chemically engineered MNAzyme platform that integrates xeno-nucleic acid modification within the catalytic core and locked nucleic acid substitution within the target-binding arms to synergistically enhance catalytic and recognition efficiency. The resulting hybrid, termed LXMz, exhibits an ∼760-fold improvement in catalytic rate and an ∼450-fold increase in sensitivity relative to the unmodified MNAzyme. Under isothermal, one-pot conditions, LXMz achieves the quantitative detection of miR-92a with a limit of detection of 2 pM while maintaining single-base specificity. By combining catalytic enhancement and hybridization stabilization within a unified molecular design, this study establishes a new chemical engineering principle for constructing robust, enzyme-free biosensors. The LXMz framework provides a versatile and sensitive platform for miRNA analysis and holds promise for liquid biopsy and point-of-care diagnostics.
- 8 November 2025
- Published by Elsevier in Biochemical Pharmacology
- Vol. 243 (Pt 2) , 117533
Gambogic acid restores wild-type-like p53 functions to induce ferroptosis in mutant p53 cancer cells
- 8 November 2025
- Published by Elsevier in Biochemical Pharmacology
- Vol. 243 (Pt 2) , 117533
Gambogic acid restores wild-type-like p53 functions to induce ferroptosis in mutant p53 cancer cells
- Open Access
LINC1467 Activates the IPO8–p65 Axis to Restrict Hand, Foot, and Mouth Disease Virus Replication
Hand–foot–mouth disease (HFMD), primarily caused by human enteroviruses (EVs), poses a public health challenge, particularly among infants, due to a lack of effective therapies. Elucidating the molecular interplay between EVs and the host immune response is crucial for developing antiviral treatments. Recent studies have highlighted the significance of long non-coding RNAs (lncRNAs) in regulating host–pathogen interactions; however, the mechanisms of lncRNAs in EV infection remain poorly unexplored. Here, we identified a highly inducible nuclear lncRNA, LINC1467, that is upregulated in response to HFMD-related EV infection. Functional analyses revealed that LINC1467 suppresses viral replication. Mechanistically, LINC1467 interacts with nuclear import receptor Importin 8 (IPO8) to form the LINC1467/IPO8/p65 complex, facilitating the phosphorylation and nuclear translocation of p65, thus promoting the expression of pro-inflammatory cytokines and activating the NF-κB pathway. The antiviral function of LINC1467 was further validated in a mouse model of viral infection. These findings uncover a novel lncRNA-mediated regulatory mechanism in the innate immune response and highlight LINC1467 as a promising target for future antiviral strategies against HFMD-related EVs.
Open AccessLINC1467 Activates the IPO8–p65 Axis to Restrict Hand, Foot, and Mouth Disease Virus Replication
Hand–foot–mouth disease (HFMD), primarily caused by human enteroviruses (EVs), poses a public health challenge, particularly among infants, due to a lack of effective therapies. Elucidating the molecular interplay between EVs and the host immune response is crucial for developing antiviral treatments. Recent studies have highlighted the significance of long non-coding RNAs (lncRNAs) in regulating host–pathogen interactions; however, the mechanisms of lncRNAs in EV infection remain poorly unexplored. Here, we identified a highly inducible nuclear lncRNA, LINC1467, that is upregulated in response to HFMD-related EV infection. Functional analyses revealed that LINC1467 suppresses viral replication. Mechanistically, LINC1467 interacts with nuclear import receptor Importin 8 (IPO8) to form the LINC1467/IPO8/p65 complex, facilitating the phosphorylation and nuclear translocation of p65, thus promoting the expression of pro-inflammatory cytokines and activating the NF-κB pathway. The antiviral function of LINC1467 was further validated in a mouse model of viral infection. These findings uncover a novel lncRNA-mediated regulatory mechanism in the innate immune response and highlight LINC1467 as a promising target for future antiviral strategies against HFMD-related EVs.
- Open Access
- 17 February 2025
- Published by MDPI AG in Marine Drugs
- Vol. 23 (2) , 87
Statins Diversity Revealed by the Deep-Sea-Derived Fungus Penicillium viridicatum
Seven new (1–7) and six known (8–13) statin derivatives were obtained from the deep-sea-derived fungus Penicillium viridicatum MCCC 3A00265. The structures assigned to the new compounds were based on a comprehensive analysis of the spectroscopic data, with absolute configurations established by Mosher analysis and biogenetic consideration. Most of the new compounds (1–5 and 7) share an octohydronaphthalene backbone, except that viridecalin F (6) possesses an uncommon naphthalene core. Viridecalins C (3) and F (6) and the two known compounds 9 and 11 exhibit considerable ability in reactivating mutant p53 protein at 10 μM, while viridecalin C showcases the most potent reactivation activity, indicating the potential of application in cancer therapy.
- 17 February 2025
- Published by MDPI AG in Marine Drugs
- Vol. 23 (2) , 87
Open AccessStatins Diversity Revealed by the Deep-Sea-Derived Fungus Penicillium viridicatum
Seven new (1–7) and six known (8–13) statin derivatives were obtained from the deep-sea-derived fungus Penicillium viridicatum MCCC 3A00265. The structures assigned to the new compounds were based on a comprehensive analysis of the spectroscopic data, with absolute configurations established by Mosher analysis and biogenetic consideration. Most of the new compounds (1–5 and 7) share an octohydronaphthalene backbone, except that viridecalin F (6) possesses an uncommon naphthalene core. Viridecalins C (3) and F (6) and the two known compounds 9 and 11 exhibit considerable ability in reactivating mutant p53 protein at 10 μM, while viridecalin C showcases the most potent reactivation activity, indicating the potential of application in cancer therapy.
- Open Access
- 8 April 2024
- Published by Springer Nature in Cell Death Discovery
- Vol. 10 (1) , 1-12
Mitochondria transcription and cancer
Mitochondria are major organelles involved in several processes related to energy supply, metabolism, and cell proliferation. The mitochondria function is transcriptionally regulated by mitochondria DNA (mtDNA), which encodes the key proteins in the electron transport chain that is indispensable for oxidative phosphorylation (OXPHOS). Mitochondrial transcriptional abnormalities are closely related to a variety of human diseases, such as cardiovascular diseases, and diabetes. The mitochondria transcription is regulated by the mtDNA, mitochondrial RNA polymerase (POLRMT), two transcription factors (TFAM and TF2BM), one transcription elongation (TEFM), and one known transcription termination factor (mTERFs). Dysregulation of these factors directly leads to altered expression of mtDNA in tumor cells, resulting in cellular metabolic reprogramming and mitochondrial dysfunction. This dysregulation plays a role in modulating tumor progression. Therefore, understanding the role of mitochondrial transcription in cancer can have implications for cancer diagnosis, prognosis, and treatment. Targeting mitochondrial transcription or related pathways may provide potential therapeutic strategies for cancer treatment. Additionally, assessing mitochondrial transcriptional profiles or biomarkers in cancer cells or patient samples may offer diagnostic or prognostic information.
- 8 April 2024
- Published by Springer Nature in Cell Death Discovery
- Vol. 10 (1) , 1-12
Open AccessMitochondria transcription and cancer
Mitochondria are major organelles involved in several processes related to energy supply, metabolism, and cell proliferation. The mitochondria function is transcriptionally regulated by mitochondria DNA (mtDNA), which encodes the key proteins in the electron transport chain that is indispensable for oxidative phosphorylation (OXPHOS). Mitochondrial transcriptional abnormalities are closely related to a variety of human diseases, such as cardiovascular diseases, and diabetes. The mitochondria transcription is regulated by the mtDNA, mitochondrial RNA polymerase (POLRMT), two transcription factors (TFAM and TF2BM), one transcription elongation (TEFM), and one known transcription termination factor (mTERFs). Dysregulation of these factors directly leads to altered expression of mtDNA in tumor cells, resulting in cellular metabolic reprogramming and mitochondrial dysfunction. This dysregulation plays a role in modulating tumor progression. Therefore, understanding the role of mitochondrial transcription in cancer can have implications for cancer diagnosis, prognosis, and treatment. Targeting mitochondrial transcription or related pathways may provide potential therapeutic strategies for cancer treatment. Additionally, assessing mitochondrial transcriptional profiles or biomarkers in cancer cells or patient samples may offer diagnostic or prognostic information.
- Open Access
- 12 July 2023
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 14, 1215995
Targeting mutant p53 stabilization for cancer therapy
Over 50% cancer bears TP53 mutation, the highly stabilized mutant p53 protein drives the tumorigenesis and progression. Mutation of p53 not only cause loss-of-function and dominant-negative effects (DNE), but also results in the abnormal stability by the regulation of the ubiquitin-proteasome system and molecular chaperones that promote tumorigenesis through gain-of-function effects. The accumulation of mutant p53 is mainly regulated by molecular chaperones, including Hsp40, Hsp70, Hsp90 and other biomolecules such as TRIM21, BAG2 and Stat3. In addition, mutant p53 forms prion-like aggregates or complexes with other protein molecules and result in the accumulation of mutant p53 in tumor cells. Depleting mutant p53 has become one of the strategies to target mutant p53. This review will focus on the mechanism of mutant p53 stabilization and discuss how the strategies to manipulate these interconnected processes for cancer therapy.
- 12 July 2023
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 14, 1215995
Open AccessTargeting mutant p53 stabilization for cancer therapy
Over 50% cancer bears TP53 mutation, the highly stabilized mutant p53 protein drives the tumorigenesis and progression. Mutation of p53 not only cause loss-of-function and dominant-negative effects (DNE), but also results in the abnormal stability by the regulation of the ubiquitin-proteasome system and molecular chaperones that promote tumorigenesis through gain-of-function effects. The accumulation of mutant p53 is mainly regulated by molecular chaperones, including Hsp40, Hsp70, Hsp90 and other biomolecules such as TRIM21, BAG2 and Stat3. In addition, mutant p53 forms prion-like aggregates or complexes with other protein molecules and result in the accumulation of mutant p53 in tumor cells. Depleting mutant p53 has become one of the strategies to target mutant p53. This review will focus on the mechanism of mutant p53 stabilization and discuss how the strategies to manipulate these interconnected processes for cancer therapy.
- 28 June 2023
- Published by Elsevier in Biochemical Pharmacology
- Vol. 214, 115666
Potent salinomycin C20-O-alkyl oxime derivative SAL-98 efficiently inhibits tumor growth and metastasis by affecting Wnt/β-catenin signal pathway
- 28 June 2023
- Published by Elsevier in Biochemical Pharmacology
- Vol. 214, 115666
Potent salinomycin C20-O-alkyl oxime derivative SAL-98 efficiently inhibits tumor growth and metastasis by affecting Wnt/β-catenin signal pathway